666 related articles for article (PubMed ID: 15024047)
21. Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice.
Stylianou E; Pepponi I; van Dolleweerd CJ; Paul MJ; Ma JK; Reljic R
Vaccine; 2011 Mar; 29(12):2279-86. PubMed ID: 21272603
[TBL] [Abstract][Full Text] [Related]
22. In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
Hesse C; Ginter W; Förg T; Mayer CT; Baru AM; Arnold-Schrauf C; Unger WW; Kalay H; van Kooyk Y; Berod L; Sparwasser T
Eur J Immunol; 2013 Oct; 43(10):2543-53. PubMed ID: 23784881
[TBL] [Abstract][Full Text] [Related]
23. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo.
Idoyaga J; Cheong C; Suda K; Suda N; Kim JY; Lee H; Park CG; Steinman RM
J Immunol; 2008 Mar; 180(6):3647-50. PubMed ID: 18322168
[TBL] [Abstract][Full Text] [Related]
24. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
25. Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity.
Schetters STT; Kruijssen LJW; Crommentuijn MHW; Kalay H; Ochando J; den Haan JMM; Garcia-Vallejo JJ; van Kooyk Y
Front Immunol; 2018; 9():990. PubMed ID: 29867967
[TBL] [Abstract][Full Text] [Related]
26. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
27. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
[TBL] [Abstract][Full Text] [Related]
28. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
29. Targeting DEC-205
Tabansky I; Keskin DB; Watts D; Petzold C; Funaro M; Sands W; Wright P; Yunis EJ; Najjar S; Diamond B; Cao Y; Mooney D; Kretschmer K; Stern JNH
Mol Med; 2018 May; 24(1):17. PubMed ID: 30134798
[TBL] [Abstract][Full Text] [Related]
30. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice.
Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797
[TBL] [Abstract][Full Text] [Related]
31. Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes.
Swee LK; Guimaraes CP; Sehrawat S; Spooner E; Barrasa MI; Ploegh HL
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1428-33. PubMed ID: 23297227
[TBL] [Abstract][Full Text] [Related]
32. DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.
Mukherjee G; Geliebter A; Babad J; Santamaria P; Serreze DV; Freeman GJ; Tarbell KV; Sharpe A; DiLorenzo TP
Int Immunol; 2013 Nov; 25(11):651-60. PubMed ID: 24021877
[TBL] [Abstract][Full Text] [Related]
33. DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes.
Bozzacco L; Trumpfheller C; Siegal FP; Mehandru S; Markowitz M; Carrington M; Nussenzweig MC; Piperno AG; Steinman RM
Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1289-94. PubMed ID: 17229838
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading.
Robson NC; Beacock-Sharp H; Donachie AM; Mowat AM
Immunology; 2003 Jul; 109(3):374-83. PubMed ID: 12807483
[TBL] [Abstract][Full Text] [Related]
35. Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response.
Sartorius R; D'Apice L; Trovato M; Cuccaro F; Costa V; De Leo MG; Marzullo VM; Biondo C; D'Auria S; De Matteis MA; Ciccodicola A; De Berardinis P
EMBO Mol Med; 2015 Jul; 7(7):973-88. PubMed ID: 25888235
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells.
Pooley JL; Heath WR; Shortman K
J Immunol; 2001 May; 166(9):5327-30. PubMed ID: 11313367
[TBL] [Abstract][Full Text] [Related]
37. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
[TBL] [Abstract][Full Text] [Related]
38. Antibody-antigen-adjuvant conjugates enable co-delivery of antigen and adjuvant to dendritic cells in cis but only have partial targeting specificity.
Kreutz M; Giquel B; Hu Q; Abuknesha R; Uematsu S; Akira S; Nestle FO; Diebold SS
PLoS One; 2012; 7(7):e40208. PubMed ID: 22808118
[TBL] [Abstract][Full Text] [Related]
39. Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune Response.
Fossum E; Tesfaye DY; Bobic S; Gudjonsson A; Braathen R; Lahoud MH; Caminschi I; Bogen B
J Immunol; 2020 Aug; 205(3):661-673. PubMed ID: 32591401
[TBL] [Abstract][Full Text] [Related]
40. Differential antigen processing by dendritic cell subsets in vivo.
Dudziak D; Kamphorst AO; Heidkamp GF; Buchholz VR; Trumpfheller C; Yamazaki S; Cheong C; Liu K; Lee HW; Park CG; Steinman RM; Nussenzweig MC
Science; 2007 Jan; 315(5808):107-11. PubMed ID: 17204652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
